Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -99.47%46.87K | 209.19%14.28M | -51.50%1.49M | 101.76%16.68M | -97.54%86.36K | 332.45%8.92M | 768.05%4.62M | -14.67%3.06M | -17.95%8.27M | -68.55%3.51M |
| Net income from continuing operations | -457.33%-4.13M | 740.85%2.72M | -130.73%-844.32K | -223.27%-18.68M | -346.02%-19.04M | 208.73%1.16M | -871.46%-424.61K | 26.77%-365.93K | -72.25%-5.78M | 12.12%-4.27M |
| Operating gains losses | 1,350.93%512.77K | -66.45%393.48K | -69.42%264.08K | 648.04%2.74M | 83.81%668.92K | 112.65%35.34K | 319.38%1.17M | 1,826.19%863.54K | -357.18%-500.07K | 260.41%363.93K |
| Depreciation and amortization | -99.74%9.92K | 38.78%2.5M | -25.29%2.63M | -2.53%11.71M | -23.44%2.58M | 17.33%3.82M | -24.25%1.8M | 16.58%3.51M | -13.02%12.02M | -12.16%3.37M |
| Asset impairment expenditure | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --5.7M | ---- |
| Remuneration paid in stock | 183.68%248.4K | 69.66%127.32K | -95.13%8.66K | 9.60%360.74K | -72.32%20.29K | -20.43%87.56K | -28.38%75.05K | 333.21%177.85K | -53.09%329.16K | -59.09%73.29K |
| Deferred tax | -69.58%707.39K | -72.48%-1.54M | 179.92%2.58M | -51.64%-6.59M | -141.83%-8.94M | 3,860.94%2.33M | -322.16%-892.64K | 183.18%921.34K | -261.71%-4.35M | -2,708.20%-3.7M |
| Other non cashItems | 23.79%857.47K | -1.37%730.76K | -5.62%694.87K | 1,096.72%27.41M | 5,175.47%25.24M | 20.04%692.69K | 24.73%740.9K | 14.90%736.23K | 11.60%2.29M | -11.56%478.38K |
| Change In working capital | 129.81%1.84M | 335.70%9.34M | -38.04%-3.84M | 81.10%-272.47K | -129.14%-435.75K | 234.96%801.66K | 158.11%2.14M | -279.22%-2.78M | 74.78%-1.44M | -87.35%1.5M |
| -Change in receivables | 130.84%745.32K | ---- | -136.71%-4.93M | 134.60%842.64K | -2,307.88%-1.02M | 3.79%-2.42M | 422.49%6.36M | -199.48%-2.08M | -13.14%-2.44M | -100.59%-42.37K |
| -Change in inventory | -471.51%-10.98M | ---- | 47.11%1.33M | 157.84%977.41K | -107.09%-43.29K | 449.42%2.96M | -415.56%-2.84M | 200.34%906.84K | -600.01%-1.69M | -36.29%610.94K |
| -Change in prepaid assets | -67.50%341.18K | ---- | 121.55%43.87K | 431.52%346.52K | -68.47%102.86K | 1,519.36%1.05M | -151.55%-602.47K | -488.32%-203.55K | -81.00%65.19K | -16.25%326.24K |
| -Change in payables and accrued expense | 257.22%1.24M | ---- | 79.10%-293.73K | -193.15%-2.44M | -12.62%524.85K | -127.72%-786.81K | 16.76%-771.85K | -549.99%-1.41M | 161.70%2.62M | -81.89%600.62K |
| -Change in other working capital | --10.5M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -99.47%46.87K | 209.19%14.28M | -51.50%1.49M | 101.76%16.68M | -97.54%86.36K | 332.45%8.92M | 768.05%4.62M | -14.67%3.06M | -17.95%8.27M | -68.55%3.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 20.28%-2.96M | -5.84%-5.36M | 46.28%-1.74M | -4.04%-16.57M | -10.35%-4.57M | -4.93%-3.71M | -6.36%-5.06M | 7.51%-3.23M | 8.87%-15.93M | 33.09%-4.14M |
| Capital expenditure reported | -40.92%-2.52M | -20.17%-2.34M | 36.93%-1.69M | 13.62%-8.74M | -19.28%-2.33M | 25.11%-1.79M | 26.90%-1.95M | 14.03%-2.67M | -3.86%-10.11M | 16.64%-1.95M |
| Net PPE purchase and sale | -42.15%-395.42K | 87.73%-24.32K | -54.67%-232.07K | -21.12%-1.06M | 11.93%1.62M | -705.81%-278.17K | 41.25%-198.16K | 46.53%-150.05K | 72.73%-875.37K | 562.47%1.45M |
| Net business purchase and sale | --0 | ---- | ---- | 0.00%-1M | --0 | 0.00%-1M | ---- | ---- | 77.34%-1M | --0 |
| Net investment purchase and sale | --0 | ---- | ---- | -3,164.00%-1.44M | -336.83%-110.98K | ---511.81K | ---795.68K | ---- | --46.86K | --46.86K |
| Net other investing changes | 67.91%-42.76K | -2.64%-3M | 145.25%183.61K | -8.85%-4.34M | -1.82%-3.75M | -16.51%-133.23K | -65.81%-2.92M | -302.04%-405.76K | -3,228.57%-3.99M | ---3.68M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 20.28%-2.96M | -5.84%-5.36M | 46.28%-1.74M | -4.04%-16.57M | -10.35%-4.57M | -4.93%-3.71M | -6.36%-5.06M | 7.51%-3.23M | 8.87%-15.93M | 33.09%-4.14M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 110.55%469.66K | -440.40%-4.05M | 80.70%-351.81K | -851.07%-5.32M | 13.36%1.7M | -2,044.00%-4.45M | 31.77%-748.65K | -1,323.33%-1.82M | -91.24%708.46K | 379.48%1.5M |
| Net issuance payments of debt | -1.78%-3.41M | -2,640.22%-3.79M | 110.38%69.6K | -172.61%-1.79M | 37.51%2.37M | -508.49%-3.35M | 75.24%-138.43K | -238.80%-670.34K | -77.69%2.47M | 288.47%1.72M |
| Net common stock issuance | --4.76M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | --25.82K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | 4.53%-619.37K | 52.65%-252.43K | 56.64%-421.41K | -135.44%-2.65M | -2,911.01%-501.03K | -74.23%-648.73K | -60.13%-533.14K | -139.59%-971.98K | 14.09%-1.13M | 84.43%-16.64K |
| Net other financing activities | 36.54%-284.41K | ---- | ---- | -38.32%-874.11K | 18.52%-168.73K | -104.15%-448.21K | 62.46%-77.08K | 12.28%-180.09K | 62.09%-631.93K | -115.52%-207.07K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 110.55%469.66K | -440.40%-4.05M | 80.70%-351.81K | -851.07%-5.32M | 13.36%1.7M | -2,044.00%-4.45M | 31.77%-748.65K | -1,323.33%-1.82M | -91.24%708.46K | 379.48%1.5M |
| Net cash flow | ||||||||||
| Beginning cash position | 45.22%7.34M | -60.19%2.44M | -63.18%3.06M | -45.52%8.3M | -21.42%5.84M | -41.74%5.06M | -59.71%6.12M | -45.52%8.3M | 4.15%15.23M | -25.09%7.43M |
| Current changes in cash | -424.39%-2.44M | 507.21%4.87M | 69.79%-600.71K | 25.05%-5.21M | -418.05%-2.78M | 160.38%753.04K | 81.74%-1.2M | -6,760.48%-1.99M | -1,120.53%-6.95M | -83.50%873.94K |
| Effect of exchange rate changes | -156.15%-14.75K | -73.68%33.53K | 91.20%-16.37K | -264.01%-32.47K | 76.46%-210 | 561.35%26.27K | 388.00%127.38K | -65,793.99%-185.91K | 126.77%19.8K | -104.00%-892 |
| End cash Position | -16.29%4.88M | 45.22%7.34M | -60.19%2.44M | -63.18%3.06M | -63.18%3.06M | -21.42%5.84M | -41.74%5.06M | -59.71%6.12M | -45.52%8.3M | -45.52%8.3M |
| Free cash from | -141.91%-2.87M | 381.85%11.91M | -280.21%-432.51K | 353.27%6.89M | -120.61%-620K | 1,992.64%6.85M | 166.96%2.47M | 20.01%240K | 5.24%-2.72M | -64.67%3.01M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.